Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
SKRR to Commence Uranium Drill Program to Test Conductors at Clearwater West (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

Healthcare Biotechnology
StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is focused on improving the early detection and management of cancer and other chronic diseases through diagnostics telehealth programs. Its lead product, Aristotle, is a mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. The Care Oncology Clinic offers a supervised treatment regimen for people diagnosed with cancer of any type or stage. AVRT is a physician-led, telehealth program for identifying and managing the early warning signs of cancer and chronic disease. Its program includes a comprehensive online health evaluation; bloodtests to measure markers of inflammation and metabolism; an initial physician consultation; regular physician follow-up appointments and interval screening. Its additional cancer diagnostics include ColonSentry and the Prostate Health Index.


TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Like Company Like Stockhouse Board
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(445)
•••
Comment by Liked2Thinkon Jul 05, 2022 11:01pm
117 Views
Post# 34804013

RE:RE:RE:RE:RE:RE:RE:Like Company Like Stockhouse Board

RE:RE:RE:RE:RE:RE:RE:Like Company Like Stockhouse BoardTheir revenue went down from Q4 to Q1.

Maybe you can chaulk that up to virtually no covid testing in Q1 but in Q4 they would have had less working days due to holidays like thanksgiving and christmas.  

Q1 should had been better than Q4.  If Q2 continues the downward trend then that is a sign to me they are heading to $0.

If CARE truely brings in close to $1M a quarter (and this was before they were a combined company which means that CARE number should also be higher as it has a benefit of more money as well) as per Tripp then how do you explain Stage only pulling in $300K a quarter.

As things continue with this company the investors are left in the dark just wondering and hoping for a miracle.  
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities